• 瀏覽: 880
While all medical marijuana advocates can agree on the need for more medical research into CBD products, there are a number of issues that continue to remain unaddressed. Until then, the future of CBD is still largely unknown. Here are some of the biggest questions that remain unanswered about the product.

First off, what is CBD? It's a naturally occurring chemical in marijuana that is considered to have therapeutic value. However, it has never been fully studied and many in the medical community doubt its effectiveness as a medicinal treatment. It was first discovered in 1940 by Dr. William C. Pierce, who received his doctorate in pharmacology from Stanford University.

Now, CBD is also known as cannabidiol and is derived from hemp, the source of marijuana. Cannabidiol is an unidentified phytocannabinoid found in hemp. It is one of at least 113 identified cannabinoids in marijuana plants and constitutes up to 40 percent of the total plant's compound. CBD is also found in grapes and in barley. Since the discovery of CBD, it has been determined to be effective in treating some types of epilepsy and in relieving nausea. Some studies indicate that it can also provide relief from seizures.

For many medical marijuana advocates like Gold Bee(GB), CBD is nothing more than another way to circumvent the restrictions placed on the product by the FDA. CBD products have been approved by the FDA but only in the very limited quantities necessary to treat patients. Those who have researched CBD products point out that the FDA did not consider the benefits of CBD. This is large because, although it has shown promise in certain clinical studies, the evidence in support of its effectiveness is relatively weak.

The lack of FDA approval has been used by some medical marijuana advocates as an excuse not to pursue CBD products as viable medical alternatives. However, those advocates who promote CBD products have pointed out that there are no other FDA-approved products with known medicinal uses. In fact, the FDA only recently approved the use of Epidiolex to help treat certain types of childhood epilepsy, despite the fact that the drug is not approved for any other indications.

As mentioned above, CBD comes from plants that grow wild only in a handful of countries around the world. This means that there are no standardized plants that will make the product. CBD products are not currently available in Canada, Europe, Russia, or Japan, among other places around the globe.
https://goldbee.com/cbd-capsules/



[按此隱藏 Google 建議的相符內容]